ストックスクリーナーアプリを入手
6.13
0.16%
0.010
アフターアワーズ：
6.01
-0.12
-1.96%
前日終値:
$6.12
開ける：
$6.15
24時間の取引高:
36,284
Relative Volume:
0.76
時価総額：
$175.44M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.45%
1か月 パフォーマンス:
+82.99%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$5.80
$6.20
1週間の範囲:
$5.50
$6.31
52週間の値動き範囲:
$2.33
$6.76
Insight Molecular Diagnostics Inc Stock (IMDX) Company Profile
名前
Insight Molecular Diagnostics Inc
セクター
電話
949-409-7600
住所
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE
IMDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMDX
Insight Molecular Diagnostics Inc
|
6.13 | 175.15M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Insight Molecular Diagnostics Inc Stock (IMDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-28 | 開始されました | Lake Street | Buy |
| 2022-05-24 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | 開始されました | Stephens | Overweight |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-03-17 | 再開されました | Needham | Buy |
| 2021-01-07 | アップグレード | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | 開始されました | BTIG Research | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | 繰り返されました | The Benchmark Company | Speculative Buy |
| 2020-07-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | 開始されました | Needham | Buy |
| 2019-02-13 | 開始されました | Piper Jaffray | Overweight |
| 2019-01-29 | アップグレード | Janney | Neutral → Buy |
| 2018-12-19 | 再開されました | Lake Street | Buy |
すべてを表示
Insight Molecular Diagnostics Inc (IMDX) 最新ニュース
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week - The Manila Times
iMDx (NASDAQ: IMDX) schedules Q3 results for Nov 10, to attend Stephens conference - Stock Titan
What MACD trends signal for Insight Molecular Diagnostics Inc. (7OC0) stockEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Is Insight Molecular Diagnostics Inc. (7OC0) stock a buy for dividend portfoliosWeekly Loss Report & Safe Capital Growth Tips - newser.com
Will Insight Molecular Diagnostics Inc. (7OC0) stock boost dividends furtherPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
U.S., Europe, and Asia Pacific Molecular Diagnostics Market - openPR.com
Is Insight Molecular Diagnostics Inc. (7OC0) stock included in top ETFs2025 EndofYear Setup & Daily Growth Stock Investment Tips - newser.com
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), TransMedics Group (TMDX) and Opko Health (OPK) - The Globe and Mail
Insight Molecular Diagnostics Advances Kidney Transplant Monitoring with New Study - TipRanks
Is Insight Molecular Diagnostics Inc. (7OC0) stock dividend growth reliablePortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
On the Move: Oct. 21, 2025 - Nashville Post
BillionToOne IPO (BLLN.US): Unique Financial Profile For Molecular Diagnostics Company, Strong Buy - Smartkarma
US Market Wrap: What earnings margins imply for Insight Molecular Diagnostics Inc. (7OC0) stockWeekly Investment Summary & Technical Buy Zone Confirmation - Trung tâm Dự báo KTTV quốc gia
What earnings margins imply for Insight Molecular Diagnostics Inc. (7OC0) stock2025 Bull vs Bear & Comprehensive Market Scan Insights - Trung tâm Dự báo KTTV quốc gia
Returns Recap: Will Insight Molecular Diagnostics Inc. (7OC0) stock maintain strong growthWeekly Risk Report & Consistent Profit Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Insight Molecular Diagnostics names Steven Tahmooressi as VP, marketing - Medical Buyer
Insight Molecular Diagnostics appoints Steven Tahmooressi as VP of Marketing - Investing.com Nigeria
Imdx welcomes new VP Marketing to prepare for commercial transplant assay launch - MarketScreener
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch - GlobeNewswire
Will Insight Molecular Diagnostics Inc. (7OC0) stock attract long term capital inflowsQuarterly Profit Report & Accurate Technical Buy Alerts - newser.com
Bullish Insight Molecular Diagnostics Insiders Rewarded As Their Investment Rises To US$4.85m - simplywall.st
Insight Molecular Diagnostics Inc.'s (NASDAQ:IMDX) large hedge funds owners must be happy as stock continues to impress, up 12% over the past week - Yahoo Finance
iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset’ with Novel Therapy and GraftAssure Monitoring - Sahm
Insight Molecular Diagnostics stock rises after transplant study publication - Investing.com
Insight Molecular Says GraftAssure Assay Helped Avoid Overtreatment in Kidney Transplant Patient - MarketScreener
Insight Molecular Diagnostics Inc (IMDX) 財務データ
Insight Molecular Diagnostics Inc (IMDX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.45%
6.29%
大文字化:
|
ボリューム (24 時間):